ABK Biomedical kicks off construction of a new Missouri-based facility, partnering with local academic and construction leaders to accelerate the development of innovative liver cancer therapies.
ABK Biomedical announced the construction kickoff of its new facility, a positive operational milestone but with no immediate financial impact.
ABK Biomedical has officially commenced construction on a new facility in Ashland, Missouri, aimed at advancing its proprietary liver cancer treatment technology. The project represents a strategic collaboration involving COR Development, Coil Construction, and the University of Missouri to scale production capabilities.
The facility is designed to advance the development and production of innovative liver cancer treatment technologies.